Research points towards early cancer detection

Key points
- A test to detect the very early stages of cancer could one day result from new research by Cardiff University scientists.
- Cardiff University is recognised in independent government assessments as one of Britain’s leading teaching and research universities.
- • Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
- A team at the University’s School of Medicine has just published a study on telomeres - small structures at the end of human chromosomes which can play a crucial part in the onset of cancer.
A test to detect the very early stages of cancer could one day result from new research by Cardiff University scientists.
A team at the University’s School of Medicine has just published a study on telomeres - small structures at the end of human chromosomes which can play a crucial part in the onset of cancer.
Telomeres control cell division in the body - by gradually becoming shorter they can tell cells when it is time to stop dividing. However when telomeres stop working properly, they can cause the cells to mutate and start dividing uncontrollably, which can lead to the formation of tumours.
The Cardiff study used ground-breaking techniques to study telomeres in human cells. The researchers found the critical length at which telomeres stop working and also that some telomeres can be shortened or deleted at random, without any external cause.
The researchers also discovered how chromosomes can fuse together once they lose the protection of their telomeres. Chromosomal fusion causes the chromosomes to disintegrate, which can result in the development of cancerous growths. The Cardiff study means there is now a system which can detect chromosomal fusions from single DNA molecules, opening up the possibility of an “early-warning” test for cancer.
Project leader Dr Duncan Baird, of the School of Medicine’s Department of Pathology, said: “This study threw up a number of significant results. The fact that telomeres can be deleted at random in otherwise normal cells indicates that some of the earliest cancerous changes can be initiated without any obvious extraneous influence. Our long-term aim with this research is to develop a clinical test to pick up these events. The fact we can now detect chromosome fusions at the single molecule level offers hope that we will be able to achieve it.”
Dr Lesley Walker, director of cancer information at Cancer Research UK, which funded the research, said: “Dr Baird and his team are making great strides in increasing our understanding of the very earliest stages of cancer by looking at these changes in single cells. It remains to be seen whether they can translate their technique and findings into a reliable test for early cancers.”
The research has just been published in the leading international journal Genes and Development.
Notes for editors
Cardiff University
Cardiff University is recognised in independent government assessments as one of Britain’s leading teaching and research universities. Founded by Royal Charter in 1883, the University today combines impressive modern facilities and a dynamic approach to teaching and research. The University’s breadth of expertise in research and research-led teaching encompasses: the humanities; the natural, physical, health, life and social sciences; engineering and technology; preparation for a wide range of professions; and a longstanding commitment to lifelong learning. Cardiff is a member of the Russell Group of the UK’s leading research universities. Visit the University website at: www.cardiff.ac.uk
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsProphylactic surgery nearly doubles in men with breast cancer
The number of men with breast cancer who undergo surgery to remove the unaffected breast has risen sharply, according to a new report by American Cancer Society and Dana Farber Cancer Institute researchers. The report,…
3 September 2015
NewsMoffitt makes important steps toward developing a blood test to catch pancreatic cancer early
Pancreatic cancer is the fourth most common cause of cancer-related death in the United States and has a 5-year survival rate of only 6 percent, which is the lowest rate of all types of cancer according to the American…
29 August 2015
NewsScientists discover cancer markers may be present early during human development
Researchers at the Virginia Bioinformatics Institute have uncovered a link between the genomes of cells originating in the neural crest and development of tumors -- a discovery that could lead to new ways to diagnose…





